19-Jun-2013 - Ambrx and Zhejiang Medicine have selected Wuxi to accelerate the development of a potential ADC (antibody drug conjugate) targeting Her2-positive breast cancer.
19-Jun-2013 - Pfizer has chosen three of Synexus' clinical research centres in South Africa to be a part of its 100-site INSPIRE programme based on the sites’ experience and audit history.
18-Jun-2013 - CRO Parexel’s massive backlog could position the company for continued revenue growth moving forward, top executives said at recent conferences.
17-Jun-2013 - Demand is at an all time high according to CRO Chiltern, which reported that its revenue grew more than 16% from the last fiscal year.
13-Jun-2013 - CRO inVentiv Health has partnered with Medikly to enhance its ability to connect with trial investigators through an online database of physicians.
12-Jun-2013 - GSK has ‘paused’ a Phase I trial of an MS drug and fired its China R&D chief, Jingwu Zhang, after finding 'manipulated' data in a paper published in Nature Medicine in...
12-Jun-2013 - Altasciences’ purchase of Vince and Associates Clinical Research highlights the industry's shift to conducting more specialized Phase I trials in patients rather than healthy volunteers, experts say.
12-Jun-2013 - Pharmas' post patent cliff push into new therapeutic areas will mean growth for the CRO industry according to Covance CEO, Joseph Herring.
12-Jun-2013 - In a rare win for a CRO, Quintiles was awarded a two-year, $1.088M research grant from the Patient-Centered Outcomes Research Institute (PCORI) to compare the effectiveness of uterine fibroid treatments.
11-Jun-2013 - Epidemiological and other medical research could be prohibitively difficult to conduct if a new European regulation is passed, according to three professors from the University of Amsterdam.
10-Jun-2013 - UK healthcare services firm ChoiceOne wants EU and US partners to help grow is Asia-focused CRO unit, Choice Pharma.
06-Jun-2013 - Three private equity firms could be ready to bid for PRA International, following indications that the US CRO would take Quintiles' lead and go public.
05-Jun-2013 - As sponsors recognize the value of adaptive clinical trial designs and regulators come on board, CROs are beginning to shift their priorities to be more flexible.
03-Jun-2013 - The EU will become more competitive thanks to new clinical trial regulations that include data transparency, says rapporteur Glenis Willmott MEP, though industry is opposed.
03-Jun-2013 - Reducing cycle times and leveraging CRO expertise will drive sponsors’ decisions in choosing partners as they look to reduce costs and oversight obligations, according to a new report.
29-May-2013 - The US FDA has sent a warning letter to a clinical investigator after he failed to take adequate action on falsified data in a study he oversaw.
28-May-2013 - Ethica Clinical Research has chosen Alion for accreditation of its Human Research Protection Program (HRPP).
27-May-2013 - Pharma and CRO executives have said that CROs could do more to be proactive in their partnerships, though some CRO executives believe that can be difficult because of the varying...
27-May-2013 - CRO ClinTec International will open an office in Istanbul, Turkey to consolidate its presence in the Middle East and North Africa region.
23-May-2013 - The Association of Clinical Research Organizations (ACRO) has joined a small business coalition as part of its effort to halt the decline of capital into biomedical research.
21-May-2013 - US House Democrats have re-introduced a bill that would expand trial data reported by companies to clinicaltrials.gov, but a recent EU court decision shows what kind of resistance should be expected....
21-May-2013 - Supplementing prospective randomized, double-blinded clinical trial data with real-world patient data holds “an enormous amount of potential” for CROs and trial sponsors, according to an expert.
20-May-2013 - CRO Harlan Laboratories has more than doubled the number of isolators at its Indianapolis and Livermore, Calif., research facilities to meet client demand for immunocompromised animal models.
20-May-2013 - Although preclinical work for CROs has fallen flat in recent quarters, Covance is looking to take advantage of the industry’s shift to early biologic developments and lead optimization.
17-May-2013 - US CRO PRA is proposing to go public again, more than six years since it was taken private, according to a confidential draft registration statement submitted to the US SEC.